Clinical Trial Details
EORTC-1419-BTG
Back to Clinical Trials Database
Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma
Trial Status | Recruiting |
---|---|
Dates |
Date of activation: 29-Jun-2015 |
Data management at EORTC | Yes |
Design |
Cross-sectional Not randomized / N.A. |
Targeted Sample size | EORTC Groups: 240 - All Groups: 640 |
Treatment |
None |
Study Staff |
Michael Weller (Study Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels Sylvie Ledroit (Clinical Operations Assistant) , EORTC Headquarters, Brussels Giulia Leonetti (Project Manager) , EORTC Headquarters, Brussels Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Arianne Marrez (Clinical Operations Manager) , EORTC Headquarters, Brussels Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Sara Nicolas (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels Jelle Stans (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Laurien Vancleef (Clinical Operations Manager) , EORTC Headquarters, Brussels Maureen Vanlancker (Clinical Research Physician) , EORTC Headquarters, Brussels Tina Verschuere (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels Xiao Mang Zhou (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels |
Type of cancer | Brain |
Participating groups |
EORTC Brain Tumor Group Brain Tumor Funders' Collaborative |
Recruiting centers |
Amsterdam UMC - locatie VUMC (Amsterdam, Netherlands) Assistance Publique - Hopitaux de Paris - Hopital Avicenne (Bobigny, France) Assistance Publique - Hopitaux de Paris - Hopital Saint-Louis (Paris, France) Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere (Paris, France) Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni - Dipartimento Neuroscienze (Torino, Italy) CHRU de Lille (Lille, France) CHU Amiens - Hopital Sud (Salouel, France) CHU Lyon - Hopital neurologique Pierre Wertheimer (Bron, France) CHU de Nice - Hopital Pasteur (Nice, France) Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland) Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America) Erasmus MC (Rotterdam, Netherlands) Haaglanden MC - locatie Antoniushove ( Leidschendam, Netherlands) Hopital Universitaires Erasme (Brussels, Belgium) Hopital de La Timone (APHM) (Marseille, France) Hygeia Hospital (Athens, Greece) IRCCS - Istituto Oncologico Veneto (Padova, Italy) Institut du Cancer de Montpellier (Montpellier, France) Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Prince Of Wales Hospital (Randwick - Sydney, Australia) UniversitaetsKlinikum Heidelberg - Head Hospital (Heidelberg, Germany) UniversitaetsSpital Zurich (Zurich, Switzerland) Universitaetsklinikum - Essen (Essen, Germany) Universitaetsklinikum Bonn (Bonn, Germany) Universitaetsklinikum Carl Gustav Carus (Dresden, Germany) Universitaetsklinikum Freiburg - Klinik fuer Neurochirurgie (Freiburg, Germany) Universitaetsklinikum Regensburg (Regensburg, Germany) Universitaetsklinikum Wien - AKH uniklinieken (Vienna, Austria) Universitaetsklinikum Wien - AKH uniklinieken (Vienna, Austria) |
Centers to be activated |
Penn State College of Medicine, Hershey Medical Center-Penn State Neuroscience Institute (Hershey, United States of America) Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany) Universitaetsklinikum Tuebingen- Crona Kliniken (Tuebingen, Germany) University Hospital Frankfurt -Senckenberg Institute of Neurooncology (Frankfurt am Main, Germany) University of California (San Francisco, United States of America) |
Protocol summary | http://clinicaltrials.gov/ct/show/ |
NCT number |